Ameriprise Financial Inc Exelixis, Inc. Transaction History

Ameriprise Financial Inc

$381 Billion
Q3 2024

A detailed history of Ameriprise Financial Inc transactions in Exelixis, Inc. stock. As of the latest transaction made, Ameriprise Financial Inc holds 1,590,990 shares of EXEL stock, worth $55.8 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,590,990

Previous 1,509,576 5.39%

Holding current value

$55.8 Million

Previous $33.9 Million 21.72%

% of portfolio

0.01%

Previous 0.01%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$21.96 - $27.6 $1.79 Million - $2.25 Million	81,414 Added 5.39%	1,590,990 $41.3 Million
Q2 2024 Aug 14, 2024	SELL	$20.34 - $23.73 $7.79 Million - $9.09 Million	-383,097 Reduced 20.24%	1,509,576 $33.9 Million
Q1 2024 May 15, 2024	BUY	$20.17 - $23.93 $678,659 - $805,172	33,647 Added 1.81%	1,892,673 $44.9 Million
Q4 2023 Feb 14, 2024	SELL	$19.25 - $24.13 $7.85 Million - $9.84 Million	-407,906 Reduced 17.99%	1,859,026 $44.6 Million
Q3 2023 Nov 14, 2023	BUY	$19.04 - $22.74 $4.17 Million - $4.97 Million	218,757 Added 10.68%	2,266,932 $49.5 Million
Q2 2023 Aug 14, 2023	SELL	$18.17 - $20.48 $4.25 Million - $4.8 Million	-234,149 Reduced 10.26%	2,048,175 $39.1 Million
Q1 2023 May 15, 2023	SELL	$16.3 - $19.41 $2.21 Million - $2.63 Million	-135,396 Reduced 5.6%	2,282,324 $44.3 Million
Q4 2022 Feb 14, 2023	SELL	$14.96 - $17.39 $1.11 Million - $1.29 Million	-74,385 Reduced 2.98%	2,417,720 $38.8 Million
Q3 2022 Nov 14, 2022	BUY	$15.68 - $22.27 $9.52 Million - $13.5 Million	606,869 Added 32.19%	2,492,105 $39.1 Million
Q2 2022 Aug 15, 2022	SELL	$17.44 - $23.16 $7.86 Million - $10.4 Million	-450,742 Reduced 19.3%	1,885,236 $39.3 Million
Q1 2022 May 16, 2022	BUY	$17.03 - $22.67 $5.97 Million - $7.94 Million	350,437 Added 17.65%	2,335,978 $53 Million
Q4 2021 Feb 14, 2022	BUY	$15.84 - $21.88 $23.7 Million - $32.7 Million	1,496,377 Added 305.9%	1,985,541 $36.3 Million
Q3 2021 Nov 15, 2021	SELL	$16.3 - $21.14 $3.53 Million - $4.57 Million	-216,348 Reduced 30.67%	489,164 $10.3 Million
Q2 2021 Aug 16, 2021	SELL	$17.95 - $25.56 $115,328 - $164,223	-6,425 Reduced 0.9%	705,512 $12.9 Million
Q1 2021 May 17, 2021	SELL	$20.53 - $25.22 $1.68 Million - $2.07 Million	-81,901 Reduced 10.32%	711,937 $16.1 Million
Q4 2020 Feb 12, 2021	BUY	$18.39 - $24.8 $1.27 Million - $1.71 Million	68,796 Added 9.49%	793,838 $15.9 Million
Q3 2020 Nov 16, 2020	SELL	$20.67 - $26.94 $4.32 Million - $5.63 Million	-208,816 Reduced 22.36%	725,042 $17.7 Million
Q2 2020 Aug 14, 2020	BUY	$16.46 - $27.42 $2.62 Million - $4.36 Million	159,170 Added 20.55%	933,858 $22.2 Million
Q1 2020 May 15, 2020	BUY	$14.46 - $21.8 $512,794 - $773,093	35,463 Added 4.8%	774,688 $13.3 Million
Q4 2019 Feb 14, 2020	SELL	$15.15 - $18.89 $1.57 Million - $1.95 Million	-103,330 Reduced 12.26%	739,225 $13 Million
Q3 2019 Nov 14, 2019	SELL	$17.68 - $22.65 $762,715 - $977,120	-43,140 Reduced 4.87%	842,555 $14.9 Million
Q2 2019 Aug 14, 2019	BUY	$18.93 - $24.75 $1.21 Million - $1.58 Million	63,675 Added 7.75%	885,695 $18.9 Million
Q1 2019 May 15, 2019	SELL	$19.6 - $24.76 $95,236 - $120,308	-4,859 Reduced 0.59%	822,020 $19.6 Million
Q4 2018 Feb 14, 2019	SELL	$13.65 - $21.8 $550,586 - $879,324	-40,336 Reduced 4.65%	826,879 $16.3 Million
Q3 2018 Nov 14, 2018	BUY	$15.87 - $22.4 $12.1 Million - $17.1 Million	762,313 Added 726.69%	867,215 $15.4 Million
Q2 2018 Aug 14, 2018	SELL	$18.56 - $22.45 $1.47 Million - $1.78 Million	-79,085 Reduced 42.98%	104,902 $2.26 Million
Q1 2018 May 15, 2018	BUY	$22.15 - $31.89 $614,197 - $884,277	27,729 Added 17.75%	183,987 $4.07 Million
Q4 2017 Feb 12, 2018	BUY	$24.23 - $30.93 $2.01 Million - $2.56 Million	82,812 Added 112.75%	156,258 $4.75 Million
Q3 2017 Nov 07, 2017	BUY	$23.35 - $29.24 $1.71 Million - $2.15 Million	73,446	73,446 $1.78 Million

Others Institutions Holding EXEL

# of Institutions

495

Shares Held

244M

Call Options Held

2.4M

Put Options Held

2.21M

View Full List

About EXELIXIS, INC.

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $11.3B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

More about EXEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Account

Ameriprise Financial Inc Exelixis, Inc. Transaction History